11. Female patients of childbearing potential (FPCP) must have a negative urine or serum pregnancy test. NOTE: FPCP is defined as premenopausal and not surgically sterilized. FPCP must agree to use effective birth control or to abstain from heterosexual activity throughout the study, starting at the first dose of lymphodepleting chemotherapy through 12 months after the infusion of cells or for 4 months after there is no evidence of persistence/ gene modified cells in the blood, whichever is longer. Effective contraceptive methods include intra-uterine device, oral or injectable hormonal contraception, or 2 adequate barrier methods (e.g. diaphragm with spermicide, cervical cap with spermicide, or female condom with spermicide). Spermicides alone are not an adequate method of contraception.